Trial intelligence / Profile preview

Sitagliptin and Exercise in Type 1 Diabetes

NCT02127047Phase 2Completed

Sponsor
University Hospital Basel
Start
Nov 2013
Primary completion
Jul 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of sitagliptin in type 1 diabetes mellitus (T1D), sponsored by University Hospital Basel. Started Nov 2013; status: completed.

02

Drugs

sitagliptin
03

Conditions

type 1 diabetes mellitus (T1D)

Beyond the preview

Go deeper on NCT02127047.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02127047.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call